WILMINGTON, Del., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (PRLD), a clinical-stage precision oncology company, today reported financial results for the second quarter ended ...
First-in-class IV SMARCA2 degrader and potentially best-in-class CDK9 inhibitor on track to generate potential proof-of-concept data in 2024 Highly selective oral SMARCA2 degrader PRT7732 IND expected ...
The Japan Mobility Show 2023 was an absolute hoot this year, showcasing a treasure trove of captivating concepts. Among the stars of the show was the revival of the Honda Prelude, a nearly ...
Honda knows how to play the car show game, which is why the Honda Prelude Concept is so unusual. Making its debut at the Japan Mobility Show 2023, the electric coupe fits Honda's outline for a ...
Honda may look to its past to revitalize its future in the electric era. A recent trademark filing suggests Honda may look to resurrect the two-door Prelude sports car as an EV. Once considered ...
Developer Pracy Studios announced the story-driven rhythm RPG, Nocturne, will launch for the Nintendo Switch and Windows PC in 2023. The developer has released a free prelude chapter, Nocturne: ...
The Japanese automaker Honda has had a momentous year in 2022. Complete with lots of best-selling introductions and a wide range of popular ideas. But was that enough? In North America, at least, ...
WILMINGTON, Del., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today reported its financial results for the fiscal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback